MUSK and myasthenia gravis: While nearly 90% of myasthenia gravis patients have autoantibodies targeting AChR and/or the muscle-specific tyrosine kinase (MuSK), other autoantibodies targeting striated muscles, particularly the sarcomere protein Titin, have been detected in some myasthenia gravis patients.